HCW Biologics Granted FDA OK for Alopecia Phase 1

 To evaluate HCW9302 in patients with moderate to severe alopecia areata

https://www.globenewswire.com/news-release/2025/02/03/3019408/0/en/HCW-Biologics-Granted-FDA-Clearance-to-Evaluate-One-of-the-Company-s-Lead-Product-Candidates-in-a-First-In-Human-Phase-1-Clinical-Trial.html